Public health officials in the United States have identified a newly emerging synthetic opioid called cychlorphine (N-propionitrile chlorphine) in the illicit drug supply. Authorities have linked the substance to several overdose deaths and have issued alerts in multiple states.
Investigators in East Tennessee reported that the compound has been associated with at least 19 deaths related to suspected drug overdoses. Toxicology investigations confirmed the presence of the substance in several cases, while additional deaths remain under review. Reports indicate that cases began to appear toward the end of 2025, with numbers increasing in early 2026.
Law enforcement agencies and forensic laboratories have also detected the drug in seized substances in other parts of the United States, including Illinois, Kentucky, Texas, Ohio, and California, suggesting a wider distribution through the illegal drug market.
Cychlorphine is a synthetic opioid, meaning it is produced in laboratories rather than derived from natural sources such as the opium poppy. Chemically, it belongs to a group of compounds structurally related to other highly potent opioids.
Early laboratory findings suggest that cychlorphine may be significantly stronger than fentanyl, a synthetic opioid already known for its high potency and role in overdose deaths. Because of this potency, even very small quantities may suppress breathing, which is the primary cause of fatal opioid overdoses.
Researchers first identified the compound in forensic drug monitoring programs around 2024, but reports of its presence in overdose cases have increased in recent years.
Authorities have confirmed cychlorphine in toxicology reports and seized drug samples in several regions of the United States. Public health agencies in Tennessee have issued community alerts after identifying the compound in multiple overdose investigations.
The U.S. Drug Enforcement Administration (DEA) has also warned that the drug may be appearing in illegal substances circulating in cities such as Chicago. Officials believe the drug may continue spreading through the illicit drug supply as new synthetic opioids are introduced.
Monitoring programs run by forensic laboratories and public health agencies are currently tracking the substance to better understand its geographic distribution.
In an exclusive interview, Todd Smith, Special Agent in Charge of the U.S. Drug Enforcement Administration’s Chicago Field Division, stated that the newly emerging drug is highly unpredictable and dangerous, and its recent appearance makes it extremely difficult to detect using current street-level testing methods.
It's extremely concerning because we've made progress. There's been a significant reduction in overdose deaths and poisonings throughout the Chicagoland area. And it's concerning that we're seeing this new substance entering the illicit drug supply.Todd Smith, Special Agent in Charge of the U.S. Drug Enforcement Administration’s Chicago Field Division
One of the major concerns surrounding cychlorphine is that individuals using illicit drugs may not know the substance is present in what they consume.
Investigators believe the compound may be mixed with other drugs, including fentanyl or stimulants. When this occurs, individuals may unknowingly consume a much stronger opioid than expected, increasing the likelihood of overdose.
Synthetic opioids often enter drug markets rapidly because small changes in chemical structure can produce new compounds that are not immediately recognized by existing monitoring systems.
Cychlorphine also presents significant challenges for detection. Routine toxicology screening used in many clinical and forensic laboratories may not automatically identify newly emerging synthetic opioids.
Some laboratories require advanced analytical testing methods to confirm the presence of such compounds. This means certain overdose cases may initially go unexplained until more detailed testing is conducted.
In addition, current drug checking tools, including commonly used rapid test strips, do not specifically detect cychlorphine. This limitation makes it more difficult for harm-reduction programs to identify the substance in community settings.
Public health agencies, toxicology laboratories, and law enforcement organizations are working together to monitor the spread of cychlorphine. Surveillance programs analyze overdose cases and drug seizure samples to detect newly emerging substances.
Officials emphasize that early identification of new synthetic opioids allows healthcare providers and emergency responders to remain prepared for potential overdose events.
As the illicit drug market continues to evolve, experts stress the importance of improved detection technologies, coordinated surveillance systems, and public health awareness to respond effectively to newly emerging substances.
(Rh/SS)